T3	Subject 27 72	3 patients with lymphoproliferative disorders
T4	Effect 89 113	acute coronary syndromes
T6	Treatment 130 165	their initial infusion of rituximab
T7	Population 27 28	3
T9	Treat-Disorder 43 72	lymphoproliferative disorders
T10	Drug 156 165	rituximab
T11	Route 144 152	infusion
T5	Adverse_event 114 124	associated
E1	Adverse_event:T5